"Results support the fact that Cinnulin PF can favorably alter body composition when consumed for at least 12 weeks," stated Dr. Tim Ziegenfuss, CEO, Ohio Research Group. "Individuals who suffer from pre-diabetes are encouraged to lose body weight to prevent the onset of type 2 diabetes. Supplementation with Cinnulin PF may help promote this weight loss while simultaneously reducing fasting blood glucose levels."
USDA studies show cinnamon promotes glucose metabolism and supports healthy cholesterol levels in individuals with type 2 diabetes. However, researchers note that when consumed consistently or in high doses, whole cinnamon and fat-soluble extracts may be toxic. Cinnulin PF, a 20:1 water extract of cinnamon, retains the active components without the potentially harmful compounds, making it completely safe for every day use. Cinnulin PF is the only cinnamon extract standardized for the recognized active component in cinnamon, double-linked Type-A Polymers.
"Cinnulin PF can potentially help the nearly 41 million individuals in the U.S. suffering from pre-diabetes reduce their symptoms and slow or possibly stop the development of type 2 diabetes," stated Tim Romero, vice president, Integrity Nutraceuticals International. "Moving forward we will continue to invest our time and resources in additional clinical studies to further validate the safety and efficacy of Cinnulin PF."
Integrity Nutraceuticals International, founded in 1999, is a global raw material supplier of bulk nutraceuticals. They import only the finest materials from China and India and specialize in custom formulations. INI's focus is to introduce innovative ingredients into the market based on science and research. Their inventory consists of a wide variety of products including: amino acids, creatine, sports enhancing supplements, joint and heath care items, specialty items and herbs. INI's products are verified analytically in their state-of-the-art in-house laboratory equipped with HPLC, FT-NIR, Microbial and heavy metals testing.